ClinicalTrials.Veeva

Menu

Efficacy of AI EF Screening by Using Smartphone Application Recorded PLAX View Cardiac Ultrasound Video Clips

R

Rayong Hospital

Status

Completed

Conditions

Cardiac Failure
Artificial Intelligence
Echocardiography
Heart Failure With Reduced Ejection Fraction
Heart Failure

Treatments

Other: Easy EF

Study type

Interventional

Funder types

Other

Identifiers

NCT06330103
RayongH

Details and patient eligibility

About

Assessing the Efficacy of Artificial Intelligence in Left Ventricular Function Screening Using Parasternal Long Axis View Cardiac Ultrasound Video Clips

ABSTRACT BACKGROUND: Echocardiography serves as a fundamental diagnostic procedure for managing heart failure patients. Data from Thailand's Ministry of Public Health reveals that there is a substantial patient population, with over 100,000 admissions annually due to this condition. Nevertheless, the widespread implementation of echocardiography in this patient group remains challenging, primarily due to limitations in specialist resources, particularly in rural community hospitals. Although modern community hospitals are equipped with ultrasound machines capable of basic cardiac assessment (e.g., parasternal long axis view), the demand for expert cardiologists remains a formidable obstacle to achieving comprehensive diagnostic capabilities. Leveraging the capabilities of Artificial Intelligence (AI) technology, proficient in the accurate prediction and processing of diverse healthcare data types, offers a promising for addressing this prevailing issue. This study is designed to assess the effectiveness of AI in evaluating cardiac performance from parasternal long axis view ultrasound video clips obtained via the smartphone application.

OBJECTIVES: To evaluate the effectiveness of artificial intelligence in screening cardiac function from parasternal long axis view cardiac ultrasound video clips obtained through the smartphone application.

Full description

METHODS: The investigators built the smartphone application to collect parasternal long axis view video clips and used artificial intelligence "Easy EF" to evaluate cardiac function. All samples that were evaluated for LVEF by certified cardiologists, 70% of all clips were used to train AI, while the remaining 30% of clips were used to test if AI could process the results correctly. Artificial intelligence aims to classify cardiac function into three groups: Reduced EF, Mildly Reduced EF, and Preserved LV.

Enrollment

923 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Shot 5 second VDO clip of Parasternal long axis heart ultrasound recorded by smartphone Application "Easy EF" without patient identification with result of Ejection fraction that performed by certify cardiologist approved result

Exclusion criteria

  • Incomplete VDO clip (too much shaking, too shot recording)
  • Lighting was inappropriate
  • Inappropriate ultrasound framing
  • arrhythmia (atrial fibrillation)

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

923 participants in 2 patient groups

LV function from cardiologist
Active Comparator group
Description:
Certified Cardiologist will access and interpreted LV function by used traditional Echocardiography then separate result into three group Preserved LV ejection fraction(EF\>50%), mildly reduce ejection fraction(EF40-49%), reduced LV ejection fraction(EF\<40%)
Treatment:
Other: Easy EF
LV function By artificial intelligence
Experimental group
Description:
AI will access VDO clips in only parasternal long axis view and separate into three group Preserved LV ejection fraction(EF\>50%), mildly reduce ejection fraction(EF40-49%), reduced LV ejection fraction(EF\<40%)
Treatment:
Other: Easy EF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems